StepStone Group LP - Q2 2022 holdings

$935 Million is the total value of StepStone Group LP's 27 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 50.0% .

 Value Shares↓ Weighting
DNB  DUN & BRADSTREET HLDGS INC$331,295,000
-14.2%
22,042,2260.0%35.44%
+23.1%
 USERTESTING INC$124,840,000
-53.0%
24,868,4710.0%13.35%
-32.6%
WKME  WALKME LTD$105,016,000
-32.9%
10,366,8550.0%11.23%
-3.7%
BHG  BRIGHT HEALTH GROUP INC$75,867,000
-5.7%
41,685,2800.0%8.12%
+35.3%
XMTR  XOMETRY INC$72,907,000
-7.7%
2,148,7450.0%7.80%
+32.4%
BuyROCKET LAB USA INC$46,593,000
-52.8%
12,293,561
+0.2%
4.98%
-32.3%
PATH  UIPATH INCcl a$32,497,000
-57.8%
1,786,5270.0%3.48%
-39.5%
 MONEYLION INCcl a$32,221,000
-47.4%
24,409,8210.0%3.45%
-24.6%
NGM  NGM BIOPHARMACEUTICALS INC$20,170,000
-15.9%
1,573,3570.0%2.16%
+20.6%
RBLX BuyROBLOX CORPcl a$15,356,000
+946.0%
468,171
+1374.6%
1.64%
+1406.4%
 DOMA HOLDINGS INC$15,326,000
-52.5%
14,879,4840.0%1.64%
-31.9%
SellROVER GROUP INC$10,714,000
-38.9%
2,849,340
-6.2%
1.15%
-12.3%
 VACASA INC$8,482,000
-65.2%
2,945,2280.0%0.91%
-50.1%
NewGROVE COLLABORATIVE HOLD INC$8,075,0001,744,065
+100.0%
0.86%
SellENTRADA THERAPEUTICS INC$7,734,000
+8.2%
634,959
-16.6%
0.83%
+55.2%
NewHILLEVAX INC$7,395,000676,567
+100.0%
0.79%
 IMAGO BIOSCIENCES INC$7,003,000
-30.5%
522,9870.0%0.75%
-0.3%
 PLANET LABS PBC$3,605,000
-14.8%
832,6080.0%0.39%
+22.5%
PHAT  PHATHOM PHARMACEUTICALS INC$3,562,000
-38.0%
422,0850.0%0.38%
-11.0%
 TENAYA THERAPEUTICS INC$2,602,000
-52.2%
462,1630.0%0.28%
-31.5%
NewHASHICORP INC$2,028,00068,891
+100.0%
0.22%
OBLG  OBLONG INC$1,145,000
-53.0%
3,692,6610.0%0.12%
-33.0%
TXG New10X GENOMICS INC$153,0003,382
+100.0%
0.02%
WMS NewADVANCED DRAIN SYS INC DEL$122,0001,354
+100.0%
0.01%
OSCR NewOSCAR HEALTH INCcl a$78,00018,450
+100.0%
0.01%
EGHT New8X8 INC NEW$73,00014,150
+100.0%
0.01%
NewCS DISCO INC$68,0003,743
+100.0%
0.01%
PCOR ExitPROCORE TECHNOLOGIES INC$0-3,665
-100.0%
-0.02%
S ExitSENTINELONE INCcl a$0-14,263
-100.0%
-0.04%
ExitFRESHWORKS INC$0-33,067
-100.0%
-0.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FIDUS INVT CORP24Q1 20199.3%
CAESARS ENTMT CORP17Q2 201734.3%
QUINSTREET INC17Q3 20173.0%
TRANSENTERIX INC16Q1 201822.6%
NOVOCURE LTD14Q2 201936.6%
CAESARS ACQUISITION CO14Q2 201729.6%
ALPHATEC HOLDINGS INC12Q2 20161.9%
ATHENE HLDG LTD10Q3 2019100.0%
REACHLOCAL INC10Q3 20150.3%
FIRST DATA CORP NEW9Q1 201965.8%

View StepStone Group LP's complete holdings history.

Latest significant ownerships (13-D/G)
StepStone Group LP Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MONEYLION INC.February 10, 202324,409,8219.6%
UserTesting, Inc.Sold outJanuary 18, 202300.0%
Forward Pharma A/SDecember 29, 202213,709,59813.8%
WalkMe Ltd.June 22, 202210,366,85512.3%
Oblong, Inc.February 11, 20223,692,66112.0%
Bright Health Group Inc.October 08, 202144,650,9377.1%
LAUREATE EDUCATION, INC.October 04, 201986,147,11639.2%
TRANSENTERIX INC.February 11, 201616,6070.0%
SafeStitch Medical, Inc.December 10, 201383,0370.0%
Patriot Coal CORPSold outFebruary 03, 201100.0%

View StepStone Group LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-02-14
13F-HR2024-02-13
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-09
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-10
SC 13G/A2023-02-10

View StepStone Group LP's complete filings history.

Compare quarters

Export StepStone Group LP's holdings